[MetO8,18]-Teriparatide
✓
データの正確性100%
24時間年中無休の科学サポート
⬡
品質に対する妥協ゼロ

在庫拠点

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート(SER)、および製品に応じた追加分析データ。

96420-15-4[MetO8,18]-Teriparatide

● 在庫あり

カタログ番号:VE0025192
CAS番号:96420-15-4
分子式:C181H291N55O53S2
分子量:4149.77 g/mol

に関する追加情報 CAS 96420-15-4

親薬物

Teriparatide

IUPAC名

L-Seryl-L-valyl-L-seryl-L-?-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-(2S)-2-amino-4-(methylsulfinyl)butanoyl-L-histidyl-Lasparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-(2S)-2-amino-4-(methylsulfinyl)butanoyl-L-?glutamyl-L-arginyl-L-valyl-L-?-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-?-aspartyl-L-valylL-histidyl-L-asparaginyl-L-phenylalanine

薬局方同義語

N/A

Other Synonyms

N/A

説明

MetO8 | 18-Teriparatide (CAS 96420-15-4) is a well-characterized oxidative impurity resulting from bioprocessing or storage-induced oxidation of methionine residues at positions 8 and 18. This modified peptide exhibits a +16 Da mass shift and distinct LC retention behavior | readily identified by HPLC-UV and confirmed by LC-MS/MS peptide mapping and accurate mass measurement. Presence of MetO8 | 18 can reduce receptor affinity and alter potency | making tight control in specifications and stability studies essential. Mitigation strategies include oxygen exclusion | controlled pH | use of antioxidants | and robust purification. Quantitative monitoring | forced-degradation studies | and validated analytical methods support regulatory-compliant impurity control.

見積もり依頼

「*」は必須フィールドを示します

このフィールドは入力チェック用です。変更しないでください。
Products quotation
Name
Url